Clavaguera et al. have demonstrated the in vivo seeding potential of brain homogenates from both tau transgenic P301S mice [23] and brain extracts from humans who had died from various tauopathies [67], while we have used synthetic preformed fibrils of K18 [24]. This evidence concerns the gene MAPT and tauopathy.